FR2756736B1 - Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline - Google Patents

Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Info

Publication number
FR2756736B1
FR2756736B1 FR9614957A FR9614957A FR2756736B1 FR 2756736 B1 FR2756736 B1 FR 2756736B1 FR 9614957 A FR9614957 A FR 9614957A FR 9614957 A FR9614957 A FR 9614957A FR 2756736 B1 FR2756736 B1 FR 2756736B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
compositions containing
indoline derivatives
sulfonyl
sulfonyl indoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9614957A
Other languages
English (en)
French (fr)
Other versions
FR2756736A1 (fr
Inventor
Jean Claude Gautier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9614957A priority Critical patent/FR2756736B1/fr
Priority to DZ970212A priority patent/DZ2362A1/xx
Priority to EP97950228A priority patent/EP0941090A1/fr
Priority to EEP199900206A priority patent/EE9900206A/xx
Priority to JP10525294A priority patent/JP2000507618A/ja
Priority to IDW990445D priority patent/ID23373A/id
Priority to HU0001386A priority patent/HUP0001386A3/hu
Priority to ARP970105696A priority patent/AR009651A1/es
Priority to RU99114019/14A priority patent/RU2174394C2/ru
Priority to IL12993697A priority patent/IL129936A0/xx
Priority to CA002273990A priority patent/CA2273990A1/fr
Priority to SK755-99A priority patent/SK75599A3/sk
Priority to ZA9710919A priority patent/ZA9710919B/xx
Priority to KR1019997004983A priority patent/KR20000069308A/ko
Priority to MYPI97005848A priority patent/MY132819A/en
Priority to TR1999/01702T priority patent/TR199901702T2/xx
Priority to CN97180304A priority patent/CN1239887A/zh
Priority to BR9712406-0A priority patent/BR9712406A/pt
Priority to CO97071118A priority patent/CO4910129A1/es
Priority to PCT/FR1997/002210 priority patent/WO1998024430A1/fr
Priority to AU53262/98A priority patent/AU716575B2/en
Priority to NZ335750A priority patent/NZ335750A/en
Publication of FR2756736A1 publication Critical patent/FR2756736A1/fr
Application granted granted Critical
Publication of FR2756736B1 publication Critical patent/FR2756736B1/fr
Priority to YU23099A priority patent/YU23099A/sr
Priority to IS5062A priority patent/IS5062A/is
Priority to NO992724A priority patent/NO992724L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FR9614957A 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline Expired - Fee Related FR2756736B1 (fr)

Priority Applications (25)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
DZ970212A DZ2362A1 (fr) 1996-12-05 1997-12-03 Compositions pharmaceutiques contenant des dérivésde n-sulfonyl indoline
TR1999/01702T TR199901702T2 (en) 1996-12-05 1997-12-04 N-Sulfonilindolin t�revleri i�eren farmas�tik bile�imler.
JP10525294A JP2000507618A (ja) 1996-12-05 1997-12-04 Ｎ−スルホニルインドリン誘導体を含有する医薬組成物
IDW990445D ID23373A (id) 1996-12-05 1997-12-04 Komposisi-komposisi farmasi yang mengandung turunan-turunan n-sulfonilindolin
HU0001386A HUP0001386A3 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives
ARP970105696A AR009651A1 (es) 1996-12-05 1997-12-04 Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas
RU99114019/14A RU2174394C2 (ru) 1996-12-05 1997-12-04 Фармацевтические композиции, содержащие производные n-сульфонилиндолина
IL12993697A IL129936A0 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives
CA002273990A CA2273990A1 (fr) 1996-12-05 1997-12-04 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
SK755-99A SK75599A3 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives
ZA9710919A ZA9710919B (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing N-sulphony-lindole derivatives
EP97950228A EP0941090A1 (fr) 1996-12-05 1997-12-04 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
MYPI97005848A MY132819A (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonylindoline derivatives
EEP199900206A EE9900206A (et) 1996-12-05 1997-12-04 N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
CN97180304A CN1239887A (zh) 1996-12-05 1997-12-04 含n－磺酰基二氢吲哚衍生物的药物组合物
BR9712406-0A BR9712406A (pt) 1996-12-05 1997-12-04 Composições farmacêuticas, contendo derivados de n-sufonil indolina
CO97071118A CO4910129A1 (es) 1996-12-05 1997-12-04 Composiciones farmaceuticas que contienen derivados de n-sulfonil indolina
PCT/FR1997/002210 WO1998024430A1 (fr) 1996-12-05 1997-12-04 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
AU53262/98A AU716575B2 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing N-sulphonylindoline derivatives
NZ335750A NZ335750A (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing N-sulphonyl indoline derivatives and a solubilizing/stabilizing system having either a nonionic hydrophilic compound having amphiphilic and surfactant properties or a mixture of an amphiphilic compound and a nonionic hydrophilic surfactant
KR1019997004983A KR20000069308A (ko) 1996-12-05 1997-12-04 Ｎ-설포닐인돌린 유도체를 포함하는 약학적 조성물
YU23099A YU23099A (en) 1996-12-05 1999-05-26 Pharmaceutical compositions containing n-sulphonyl indolin derivatives
IS5062A IS5062A (is) 1996-12-05 1999-06-01 Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
NO992724A NO992724L (no) 1996-12-05 1999-06-04 Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (2)

Publication Number Publication Date
FR2756736A1 FR2756736A1 (fr) 1998-06-12
FR2756736B1 true FR2756736B1 (fr) 1999-03-05

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9614957A Expired - Fee Related FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Country Status (25)

Country Link
EP (1) EP0941090A1 (pt)
JP (1) JP2000507618A (pt)
KR (1) KR20000069308A (pt)
CN (1) CN1239887A (pt)
AR (1) AR009651A1 (pt)
AU (1) AU716575B2 (pt)
BR (1) BR9712406A (pt)
CA (1) CA2273990A1 (pt)
CO (1) CO4910129A1 (pt)
DZ (1) DZ2362A1 (pt)
EE (1) EE9900206A (pt)
FR (1) FR2756736B1 (pt)
HU (1) HUP0001386A3 (pt)
ID (1) ID23373A (pt)
IL (1) IL129936A0 (pt)
IS (1) IS5062A (pt)
MY (1) MY132819A (pt)
NO (1) NO992724L (pt)
NZ (1) NZ335750A (pt)
RU (1) RU2174394C2 (pt)
SK (1) SK75599A3 (pt)
TR (1) TR199901702T2 (pt)
WO (1) WO1998024430A1 (pt)
YU (1) YU23099A (pt)
ZA (1) ZA9710919B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
ZA9710919B (en) 1999-06-04
CN1239887A (zh) 1999-12-29
DZ2362A1 (fr) 2002-12-28
EE9900206A (et) 1999-12-15
WO1998024430A1 (fr) 1998-06-11
HUP0001386A2 (hu) 2001-04-28
NO992724D0 (no) 1999-06-04
KR20000069308A (ko) 2000-11-25
FR2756736A1 (fr) 1998-06-12
ID23373A (id) 2000-04-20
AR009651A1 (es) 2000-04-26
IS5062A (is) 1999-06-01
AU716575B2 (en) 2000-03-02
TR199901702T2 (en) 1999-09-21
IL129936A0 (en) 2000-02-29
BR9712406A (pt) 1999-08-31
MY132819A (en) 2007-10-31
RU2174394C2 (ru) 2001-10-10
NZ335750A (en) 2001-06-29
JP2000507618A (ja) 2000-06-20
SK75599A3 (en) 2000-08-14
YU23099A (en) 1999-11-22
NO992724L (no) 1999-06-04
CA2273990A1 (fr) 1998-06-11
CO4910129A1 (es) 2000-04-24
AU5326298A (en) 1998-06-29
HUP0001386A3 (en) 2002-03-28
EP0941090A1 (fr) 1999-09-15

Similar Documents

Publication Publication Date Title
MA26453A1 (fr) Derives de 6-phenylpyridyl-2 amine et compositions pharmaceutiques les contenant
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DK0747050T3 (da) Farmaceutiske sammensætninger indeholdende irbesartan
PT1066027E (pt) Composicao farmaceutica de topiramato
PT907364E (pt) Composicao farmaceutica de libertacao sustida
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
BR9605309A (pt) Composições de derivados piperazina
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
ID22973A (id) Komposisi farmasi dari pemberian oral dari turunan n-piperidino-3-pirazolkarboksamida, garam-garam dan solvatnya
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
MA26526A1 (fr) Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26559A1 (fr) Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
IS5317A (is) Föst lyfjasamsetning sem inniheldur bensófúran afleiður
DE69401823D1 (de) Indolin derivate als 5ht2c antagonisten
FI962969A (fi) Indolijohdannaisia 5-HT1:n agonisteina
PT1014987E (pt) Composicoes orais de levosimendano
MA24632A1 (fr) Derives de 2-(4-aryl-ou heteroaryl-piperazine-1-ylmethyle)-1h- indole
FR2756736B1 (fr) Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline
IL118424A0 (en) Pharmaceutical compositions containing benzimidazole derivative
ATE207076T1 (de) Ara-c derivate
PT941100E (pt) Composicoes farmaceuticas
FR2763842B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant des derives de threonine ou de serine
ATE193701T1 (de) Substituierte indol-derivate
IL119844A0 (en) Substituted indole derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse